Report from the 25th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Gastric and Gastroesophageal Cancers, Winnipeg, Manitoba, 26-27 October 2023

Ralph Wong; Brady Anderson; Bashir Bashir; Justin Bateman; Haji Chalchal; Janine Davies; Anahita Dehmoobed; Georgia Geller; Abhijit Ghose; Sharlene Gill; Vallerie Gordon; Susan Green; Pamela Hebbard; Mussawar Iqbal; Shuying Ji; Hatim Karachiwala; Biniam Kidane; Christina Kim; Ekaterina Kosyachkova; Marianne Krahn; Tharani Krishnan; Mark Kristjanson; Sangjune Lee; Richard Lee-Ying; Stephanie Lelond; Hong-Wei Liu; Daniel Meyers; Karen Mulder; James Paul; Elvira Planincic

doi:10.3390/curroncol31100447

Report from the 25th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Gastric and Gastroesophageal Cancers, Winnipeg, Manitoba, 26-27 October 2023

Curr Oncol. 2024 Oct 7;31(10):5987-6006. doi: 10.3390/curroncol31100447.

Authors

Ralph Wong¹, Brady Anderson², Bashir Bashir¹, Justin Bateman³, Haji Chalchal⁴, Janine Davies⁵, Anahita Dehmoobed¹, Georgia Geller⁶, Abhijit Ghose⁷, Sharlene Gill⁵, Vallerie Gordon¹, Susan Green¹, Pamela Hebbard¹, Mussawar Iqbal⁸, Shuying Ji⁹, Hatim Karachiwala¹⁰, Biniam Kidane¹¹, Christina Kim¹, Ekaterina Kosyachkova¹², Marianne Krahn¹, Tharani Krishnan⁵, Mark Kristjanson¹, Sangjune Lee¹³, Richard Lee-Ying¹⁰, Stephanie Lelond¹, Hong-Wei Liu¹⁴, Daniel Meyers¹, Karen Mulder¹⁵, James Paul¹, Elvira Planincic¹

Affiliations

¹ CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
² Western Manitoba Cancer Center, Brandon, MB R7A 5M8, Canada.
³ Royal Alexandra Hospital, Edmonton, AB T5H 3V9, Canada.
⁴ Allan Blair Cancer Centre, Regina, SK S4T 7T1, Canada.
⁵ BC Cancer Centre, Vancouver, BC V5Z 4E6, Canada.
⁶ BC Cancer Centre, Victoria, BC V8R 6V5, Canada.
⁷ Chinook Regional Hospital, Lethbridge, AB T1J 1W5, Canada.
⁸ Saskatchewan Cancer Agency, Regina, SK S4T 7T1, Canada.
⁹ Shared Health Manitoba, Winnipeg, MB R2N 0E2, Canada.
¹⁰ Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
¹¹ Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3A 1R9, Canada.
¹² My Gut Feeling-Stomach Cancer Foundation of Canada, Toronto, ON M5A 4T7, Canada.
¹³ Department of Oncology, University of Calgary, Calgary, AB T2N 4N2, Canada.
¹⁴ Central Alberta Cancer Center, Red Deer, AB T4N 6R2, Canada.
¹⁵ Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.

Abstract

The 25th Annual Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held in Winnipeg, Manitoba, on 26-27 October 2023. The WCGCCC is an interactive multidisciplinary conference that was attended by healthcare professionals from across Western Canada (British Columbia, Alberta, and Manitoba) who are involved in the care of patients with gastrointestinal cancer. Surgical, medical, and radiation oncologists; pathologists; oncology nurses; pharmacists; and a family physician in oncology (FPO) participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of gastroesophageal cancers.

Keywords: HER2; adjuvant; biomarker-directed therapy; gastric cancer; gastroesophageal cancer; predictive biomarkers; surgical management; survivorship; systemic therapies.

Publication types

Congress

MeSH terms

Canada
Esophageal Neoplasms* / therapy
Gastrointestinal Neoplasms / therapy
Humans
Manitoba
Stomach Neoplasms* / therapy

Grants and funding

The 2023 WCGCCC received unrestricted educational grants from Pfizer Canada, Eisai Canada, Amgen Canada, Astellas Pharma Canada, Incyte, Merck Canada, Taiho Pharmaceutical, Bayer Canada, Takeda Canada, Ipsen Biopharmaceuticals, Organon Biosciences, F. Hoffman-La Roche, BeiGene, Bristol-Myers Squibb Canada, and AstraZeneca Canada. During the entire process, sponsors had no influence whatsoever over the development of the guidelines and they did not review or read the guidelines before submission. No author was compensated for their work on this article.